BDI Cancer Research Results

BDI, Beck Depression Inventory: Click to Expand ⟱
Source:
Type:

Beck Depression Inventory

Abbreviation: BDI, BDI-II

Type: Clinical outcome / self-reported depression severity scale

Function: The Beck Depression Inventory is a 21-item self-report questionnaire used to measure the presence and severity of depressive symptoms. The BDI-II is the revised version and is widely used in clinical and research settings.

Scoring: Each BDI-II item is scored from 0 to 3, producing a total score from 0 to 63. Higher scores indicate greater depressive symptom severity.

Depression: ↑ BDI or BDI-II score indicates greater depressive symptom burden.

Favorable Direction: ↓ BDI or BDI-II score is favorable and indicates improvement in depressive symptoms.
Scientific Papers found: Click to Expand⟱
8441- OM,    The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson's disease: A randomized controlled pilot study
- Trial, Park, NA
*NMSS↓, *BDI↓, *UPDRSIII∅, *motorD↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

BDI↓, 1,   NMSS↓, 1,   UPDRSIII∅, 1,  

Functional Outcomes(tgid=23) ⓘ

motorD↑, 1,  
Total Targets: 4

Scientific Paper Hit Count for: BDI, Beck Depression Inventory
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1836  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page